Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $3.2 million.

  • Arcturus Therapeutics Holdings' Other Non Operating Income fell 1529.6% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year decrease of 163.58%. This contributed to the annual value of $15.2 million for FY2024, which is 5524.7% down from last year.
  • Arcturus Therapeutics Holdings' Other Non Operating Income amounted to $3.2 million in Q3 2025, which was down 1529.6% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Other Non Operating Income registered a high of $34.0 million during Q1 2023, and its lowest value of -$3.8 million during Q4 2022.
  • Moreover, its 5-year median value for Other Non Operating Income was $2.7 million (2025), whereas its average is $3.5 million.
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Other Non Operating Income crashed by 228181.82% in 2021 and then skyrocketed by 612003.55% in 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Other Non Operating Income (Quarter) stood at -$524000.0 in 2021, then tumbled by 631.87% to -$3.8 million in 2022, then soared by 203.81% to $4.0 million in 2023, then fell by 19.27% to $3.2 million in 2024, then rose by 0.62% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $2.6 million for Q2 2025, and $2.8 million during Q1 2025.